openPR Logo
Press release

Sali Family Assumes Leadership of Seid Medical GmbH, Strengthening Legacy and Expanding Capabilities

05-03-2025 01:34 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: Kjprnews
Sali Family Assumes Leadership of Seid Medical GmbH,

Denkingen, Germany - A generational transition in leadership has taken place at Seid Medical GmbH, a long-established medical technology company headquartered in Denkingen. The company, formerly known as Seid and founded in 1959, has been acquired by the Sali family, with Eugen Sali and his sons Alex and Maik assuming management responsibilities.

The new leadership structure comprises Eugen Sali (51), an experienced industrial and surgical mechanic, and his sons Alex (32), a master craftsman in metalworking, and Maik (26), a trained surgical mechanic. All three bring independent professional experience in the medical technology sector, previously operating their own enterprises. The transition consolidates their activities under a single operational base in Denkingen, uniting a team of 21 employees in total.

Seid Medical GmbH is recognized nationally and internationally for its specialization in ENT instruments, particularly specula. Under new management, the company has retained its core product line while introducing surgical instruments such as breast lifters for aesthetic procedures, micro ear forceps, and nasal polyp clippers. These additions were made in response to evolving industry requirements.

In addition to expanding its portfolio, the company has enhanced production capacity and capabilities. It now accepts orders from other medical technology firms for specialized services, including TIG welding, laser welding, assembly, and surface finishing. These services are intended to support the broader manufacturing needs of regional partners in the Tuttlingen district.

Seid Medical GmbH operates as a manufacturer supplying medical devices to industry distributors, who manage legal, regulatory, and documentation obligations. The company does not sell directly to clinics or end users.

Following the acquisition, Seid Medical GmbH reports an improvement in recruitment, citing current market conditions as favorable for attracting skilled personnel. Future plans include increased investment in the development and production of surgical instruments aimed at addressing identified gaps in the medical device market.

The leadership team emphasizes that the success of this transition rests not only on strategic initiatives but also on maintaining strong collaboration within the family-led management structure.
Media Contact
Company Name: Seid Medical GmbH
Contact Person: Media Relations
Email: Send Email [http://www.universalpressrelease.com/?pr=sali-family-assumes-leadership-of-seid-medical-gmbh-strengthening-legacy-and-expanding-capabilities]
Phone: +49 7424 1316
Country: Germany
Website: http://www.seid-instrumente.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sali Family Assumes Leadership of Seid Medical GmbH, Strengthening Legacy and Expanding Capabilities here

News-ID: 3998117 • Views:

More Releases from Getnews

Faith Through Fire How One Woman's Battle With a Rare Disease Became a Story of God's Grace
Faith Through Fire How One Woman's Battle With a Rare Disease Became a Story of …
Diagnosed at just thirteen days old with a rare genetic disorder known as Maple Syrup Urine Disease (MSUD), Elizabeth Alison Stone was thrust into a world of uncertainty, strict medical regimens, and life-threatening challenges. In her new memoir, Pursuing God's Grace [https://www.amazon.com/Pursuing-Grace-Elizabeth-Alison-Stone/dp/B0F5JK8DB1/ref], Stone opens the door to her personal story of resilience, survival, and unshakable faith. Image: https://www.globalnewslines.com/uploads/2025/10/9ddde09dd4e20f6f56a558e37b024a42.jpg Through this deeply moving account, readers are invited to walk alongside Elizabeth as she
Readers' Favorite recognizes
Readers' Favorite recognizes "The Regression Strain" in its annual international …
Image: https://www.globalnewslines.com/uploads/2025/10/1759937772.jpg Readers' Favorite recognizes "The Regression Strain" by Kevin Hwang in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0F9Q1L4KV. The Readers' Favorite International Book Award Contest featured thousands of contestants from over a dozen countries, ranging from new independent authors to NYT best-sellers and celebrities. Readers' Favorite is one of the largest book review and award contest sites on the Internet. They have earned the respect of renowned publishers like
AquaShear Hydraulic Mixer: Breaking the Billion-Dollar Industrial Mixing Bottleneck with Proven Hydraulic Technology
AquaShear Hydraulic Mixer: Breaking the Billion-Dollar Industrial Mixing Bottlen …
Image: https://www.globalnewslines.com/uploads/2025/10/8013919c55e3b21e0846e4550d226f1d.jpg Across industries such as energy, water treatment, food processing, mining, and petrochemical refining, inefficient mixing has long been one of the most expensive bottlenecks. From delayed batches and wasted additives to clogged systems and costly downtime, the ripple effects of poor mixing add up to billions in annual losses for industrial operations. The newly relaunched AquaShear [http://aquashearusa.com?utm_source=release&utm_medium=press&utm_campaign=sept_2025] brand by Johnson Specialty Tools is stepping in with a patented approach
Readers' Favorite recognizes
Readers' Favorite recognizes "Pioneering Prosperity" in its annual international …
Image: https://www.globalnewslines.com/uploads/2025/10/1759937647.jpg Readers' Favorite recognizes "Pioneering Prosperity" by Joyce Brand in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0D3HW2XRK. [http://www.amazon.com/gp/product/B0D3HW2XRK] The Readers' Favorite International Book Award Contest featured thousands of contestants from over a dozen countries, ranging from new independent authors to NYT best-sellers and celebrities. Image: https://m.media-amazon.com/images/I/41oWYhdMCvL._SL400_.jpg Readers' Favorite is one of the largest book review and award contest sites on the Internet. They have earned the respect of renowned publishers

All 5 Releases


More Releases for Seid

Vaginal And Vulval Inflammatory Disease Treatment Market Forecast 2025-2034: Com …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics. What Is the Projected Growth of the Vaginal And Vulval Inflammatory Disease Treatment Market? In recent times, the market for treatment of vaginal and vulval inflammatory diseases has exhibited robust growth. The market, which will expand from $2.87 billion in 2024 to $3.06 billion in 2025, is expected to grow at a compound annual
Vaginal And Vulval Inflammatory Disease Treatment Market Forecast 2025-2034: Eva …
What industry-specific factors are fueling the growth of the vaginal and vulval inflammatory disease treatment market? The surge in diabetes cases is projected to drive the expansion of the market for treatments of vaginal and vulval inflammatory diseases. Diabetes is a persistent medical disorder typified by high levels of blood sugar resulting from the body's lack of or ineffective use of insulin. Sedentary lifestyle patterns, poor eating habits, increasing rates
The Increasing Incidence Of Diabetes Is Driving Market Growth Driver: A Crucial …
What Is the Expected Size and Growth Rate of the Vaginal And Vulval Inflammatory Disease Treatment Market? In the past few years, there has been a robust growth in the market size of treatments for vaginal and vulval inflammatory diseases. It is projected to expand from $2.87 billion in 2024 to $3.06 billion in 2025, boasting a compound annual growth rate (CAGR) of 6.65%. This growth during the historic period
MTMG Launches with a Commitment to Problem Solving and Putting Their Experience …
[Boxford, Massachusetts and Oola, Limerick, Republic of Ireland)] - 19th March, 2024 - MTMG, a new provider of IT, Telecom, and Mobile consulting solutions, today announced the commencement of its US-Based operations, rooted in the lifelong vision of its founder, Paul Knittle. "I've always wanted to establish a company where we are all focused on one mission - to put our collective experience toward helping clients solve problems," Knittle said.
Mira Sound Germany releases Michel Montecrossa's 'The Jesus Symphony Live Concer …
'The Jesus Symphony Live Concert' released by Mira Sound Germany as DVD is Michel Montecrossa's twenty-eigth concert of the Courage & Love Climate Change Concert Tour 2009. 'The Jesus Symphony' composed by Michel Montecrossa is a modern Christian Spiritual Symphony for electronic instruments, choir and solo chants in English and German language based on the Gospel of Thomas. 'The Jesus Symphony' is modern classical music of light and love in honor of
The Jesus Symphony – New CD Release by Michel Montecrossa
Michel Montecrossa's profound 'Jesus Symphony' released by Mira Sound Germany as Audio-CD with 6 orchestral and 5 solo chant tracks is dedicated to the life and message of Jesus. Michel Montecrossa has written the lyrics of the song-chants on the basis of the Gospel of Thomas. 'The Jesus Symphony' is performed by Michel Montecrossa and his Lightsound Orchestra. The vocals are performed in English and German by Michel Montecrossa. Michel Montecrossa about 'The